- Home
- IMOS vs CRMD Comparison
IMOS vs CRMD Comparison
Compare IMOS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMOS | CRMD |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.5M | 876.7M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | IMOS | CRMD |
|---|---|---|
| Price | $27.94 | $10.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $17.43 |
| AVG Volume (30 Days) | 24.1K | ★ 3.1M |
| Earning Date | 11-11-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.01 | ★ 2.25 |
| Revenue | ★ $748,307,671.00 | $214,303,672.00 |
| Revenue This Year | $5.78 | $627.89 |
| Revenue Next Year | $10.84 | $40.95 |
| P/E Ratio | $129.31 | ★ $4.69 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $12.78 | $5.60 |
| 52 Week High | $30.98 | $17.43 |
Technical Indicators
Market Signals| Indicator | IMOS | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.98 | 51.56 |
| Support Level | $27.55 | $9.20 |
| Resistance Level | $28.36 | $9.88 |
| Average True Range (ATR) | 0.89 | 0.51 |
| MACD | -0.26 | 0.10 |
| Stochastic Oscillator | 53.45 | 67.76 |
Price Performance
Historical ComparisonAbout IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.